Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

53 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Measurement of metabolic tumor volume: static versus dynamic FDG scans.
Cheebsumon P, van Velden FH, Yaqub M, Hoekstra CJ, Velasquez LM, Hayes W, Hoekstra OS, Lammertsma AA, Boellaard R. Cheebsumon P, et al. Among authors: hoekstra os, hoekstra cj. EJNMMI Res. 2011 Dec 14;1:35. doi: 10.1186/2191-219X-1-35. EJNMMI Res. 2011. PMID: 22214394 Free PMC article.
Measuring response to therapy using FDG PET: semi-quantitative and full kinetic analysis.
Cheebsumon P, Velasquez LM, Hoekstra CJ, Hayes W, Kloet RW, Hoetjes NJ, Smit EF, Hoekstra OS, Lammertsma AA, Boellaard R. Cheebsumon P, et al. Among authors: hoekstra os, hoekstra cj. Eur J Nucl Med Mol Imaging. 2011 May;38(5):832-42. doi: 10.1007/s00259-010-1705-9. Epub 2011 Jan 6. Eur J Nucl Med Mol Imaging. 2011. PMID: 21210109 Free PMC article.
Partial volume correction strategies for quantitative FDG PET in oncology.
Hoetjes NJ, van Velden FH, Hoekstra OS, Hoekstra CJ, Krak NC, Lammertsma AA, Boellaard R. Hoetjes NJ, et al. Among authors: hoekstra os, hoekstra cj. Eur J Nucl Med Mol Imaging. 2010 Aug;37(9):1679-87. doi: 10.1007/s00259-010-1472-7. Epub 2010 Apr 27. Eur J Nucl Med Mol Imaging. 2010. PMID: 20422184 Free PMC article.
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0.
Boellaard R, O'Doherty MJ, Weber WA, Mottaghy FM, Lonsdale MN, Stroobants SG, Oyen WJ, Kotzerke J, Hoekstra OS, Pruim J, Marsden PK, Tatsch K, Hoekstra CJ, Visser EP, Arends B, Verzijlbergen FJ, Zijlstra JM, Comans EF, Lammertsma AA, Paans AM, Willemsen AT, Beyer T, Bockisch A, Schaefer-Prokop C, Delbeke D, Baum RP, Chiti A, Krause BJ. Boellaard R, et al. Among authors: hoekstra os, hoekstra cj. Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):181-200. doi: 10.1007/s00259-009-1297-4. Eur J Nucl Med Mol Imaging. 2010. PMID: 19915839 Free PMC article.
The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials.
Boellaard R, Oyen WJ, Hoekstra CJ, Hoekstra OS, Visser EP, Willemsen AT, Arends B, Verzijlbergen FJ, Zijlstra J, Paans AM, Comans EF, Pruim J. Boellaard R, et al. Among authors: hoekstra os, hoekstra cj. Eur J Nucl Med Mol Imaging. 2008 Dec;35(12):2320-33. doi: 10.1007/s00259-008-0874-2. Epub 2008 Aug 15. Eur J Nucl Med Mol Imaging. 2008. PMID: 18704407
How should we analyse FDG PET studies for monitoring tumour response?
Lammertsma AA, Hoekstra CJ, Giaccone G, Hoekstra OS. Lammertsma AA, et al. Among authors: hoekstra os, hoekstra cj. Eur J Nucl Med Mol Imaging. 2006 Jul;33 Suppl 1:16-21. doi: 10.1007/s00259-006-0131-5. Eur J Nucl Med Mol Imaging. 2006. PMID: 16763817 Review.
Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer.
Hoekstra CJ, Stroobants SG, Smit EF, Vansteenkiste J, van Tinteren H, Postmus PE, Golding RP, Biesma B, Schramel FJ, van Zandwijk N, Lammertsma AA, Hoekstra OS. Hoekstra CJ, et al. Among authors: hoekstra os. J Clin Oncol. 2005 Nov 20;23(33):8362-70. doi: 10.1200/JCO.2005.01.1189. J Clin Oncol. 2005. PMID: 16293866 Clinical Trial.
Positron emission tomography using 2-deoxy-2-[18F]-fluoro-D-glucose for response monitoring in locally advanced gastroesophageal cancer; a comparison of different analytical methods.
Kroep JR, Van Groeningen CJ, Cuesta MA, Craanen ME, Hoekstra OS, Comans EF, Bloemena E, Hoekstra CJ, Golding RP, Twisk JW, Peters GJ, Pinedo HM, Lammertsma AA. Kroep JR, et al. Among authors: hoekstra os, hoekstra cj. Mol Imaging Biol. 2003 Sep-Oct;5(5):337-46. doi: 10.1016/j.mibio.2003.09.007. Mol Imaging Biol. 2003. PMID: 14630513
53 results